Glutaredoxin-1 mediates NADPH-dependent stimulation of calcium-dependent insulin secretion
about
Redox homeostasis in pancreatic β cellsThioredoxins, glutaredoxins, and peroxiredoxins--molecular mechanisms and health significance: from cofactors to antioxidants to redox signalingEukaryotic translation initiation factor 3 subunit e controls intracellular calcium homeostasis by regulation of cav1.2 surface expressionDeSUMOylation Controls Insulin Exocytosis in Response to Metabolic Signals.Differential expression of islet glutaredoxin 1 and 5 with high reactive oxygen species production in a mouse model of diabesityNNT reverse mode of operation mediates glucose control of mitochondrial NADPH and glutathione redox state in mouse pancreatic β-cells.Regulation of insulin secretion: role of mitochondrial signalling.Control of the intracellular redox state by glucose participates in the insulin secretion mechanismThioredoxin-like 2 regulates human cancer cell growth and metastasis via redox homeostasis and NF-κB signalingA role for cytosolic isocitrate dehydrogenase as a negative regulator of glucose signaling for insulin secretion in pancreatic ß-cells.Optogenetic control of insulin secretion in intact pancreatic islets with β-cell-specific expression of Channelrhodopsin-2.Isocitrate-to-SENP1 signaling amplifies insulin secretion and rescues dysfunctional β cellsNAD kinase regulates the size of the NADPH pool and insulin secretion in pancreatic β-cells.Insulin release, peripheral insulin resistance and muscle function in protein malnutrition: a role of tricarboxylic acid cycle anaplerosis.Signal integration at the level of ion channel and exocytotic function in pancreatic β-cells.Overcoming the spatial barriers of the stimulus secretion cascade in pancreatic β-cells.Role of K(ATP) channels in β-cell resistance to oxidative stress.Metabolic fate of glucose and candidate signaling and excess-fuel detoxification pathways in pancreatic β-cells.Adenylosuccinate Is an Insulin Secretagogue Derived from Glucose-Induced Purine Metabolism.The Pancreatic β-Cell: A Bioenergetic Perspective.Glutaredoxin-1 Deficiency Causes Fatty Liver and Dyslipidemia by Inhibiting Sirtuin-1.Optimal elevation of β-cell 11β-hydroxysteroid dehydrogenase type 1 is a compensatory mechanism that prevents high-fat diet-induced β-cell failure.Transcribing β-cell mitochondria in health and disease.N-acetylcysteine protects pancreatic islet against glucocorticoid toxicity.Pregnancy restores insulin secretion from pancreatic islets in cafeteria diet-induced obese rats.Time-resolved metabolomics analysis of β-cells implicates the pentose phosphate pathway in the control of insulin release.Acute nutrient regulation of the mitochondrial glutathione redox state in pancreatic β-cells.Distinct Shift in Beta-Cell Glutaredoxin 5 Expression Is Mediated by Hypoxia and Lipotoxicity Both In Vivo and In Vitro.
P2860
Q27021930-88ED9727-8419-416C-AEF6-7B5CCA045C48Q28389739-105F572E-E3F1-4076-994F-8031B42C7ED6Q28565129-69DF5B81-FA49-4923-8C53-62AC0422B3A1Q33649512-2C7EC454-FC21-4B58-A287-07AA607A4275Q33724707-BA693718-CC02-4D04-9EF3-14A793E71B38Q33726651-AE3C9EA5-1761-44B8-96F1-D726F320CA6DQ33914248-40E7002B-DA67-4822-8443-86302867B200Q34016498-C52A166A-4500-48A8-9E0F-683AC400D436Q34428947-87EC422E-43F1-45F2-8A8B-11224F259461Q35018731-7C05ED03-5C4A-48B1-825A-7483DD2D2AFDQ36121997-A4C20E0A-B6D9-4E03-8737-158B56FC4619Q36165625-97DDA25C-9FBC-49A0-95CC-13DE36987157Q36200527-5DC9E20B-782B-4810-A122-CEA79335095CQ37641409-2B32C228-65B0-4E6D-8C56-D70CE0B33043Q37936038-C4AC7120-5809-4D87-BBF2-B2AF2A6770FCQ37964899-9FEC5181-C692-455B-BE97-ED76FC6EBCFFQ38038657-28A513B6-094A-46D9-B986-1A76F8586AF1Q38712872-DA50A526-D4F3-49BA-AA06-B38C2708DD39Q38832035-24E8EC3F-B7BE-4185-B428-30A026631F9FQ38943061-B4DF2E09-FBC2-495C-846B-78BB41F136E9Q39105659-CF70FE63-38B1-499B-837B-04B04D2D745FQ41314761-1420BF09-1CD9-4300-8855-1CD3633181F0Q41689696-EDDB6519-9E7D-4401-81C8-702B4FAB3449Q42727085-16FC2EFD-4A8F-4B05-8BA4-146C514E571FQ43244099-ED6C0599-ADC5-44C3-8459-4ECADF386190Q46907985-6747911D-F3CE-43F8-AD1D-40A7D8B83E0BQ46912910-A00F8FFF-696E-4858-A711-AE1F0E7B05D1Q51733140-969FACCD-D27C-40A3-B0C6-A542D8E58858
P2860
Glutaredoxin-1 mediates NADPH-dependent stimulation of calcium-dependent insulin secretion
description
2009 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հունիսին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2009
@ast
im März 2009 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2009/06/01)
@sk
vědecký článek publikovaný v roce 2009
@cs
wetenschappelijk artikel (gepubliceerd op 2009/06/01)
@nl
наукова стаття, опублікована в червні 2009
@uk
مقالة علمية (نشرت في يونيو 2009)
@ar
name
Glutaredoxin-1 mediates NADPH- ...... um-dependent insulin secretion
@ast
Glutaredoxin-1 mediates NADPH- ...... um-dependent insulin secretion
@en
Glutaredoxin-1 mediates NADPH- ...... um-dependent insulin secretion
@nl
type
label
Glutaredoxin-1 mediates NADPH- ...... um-dependent insulin secretion
@ast
Glutaredoxin-1 mediates NADPH- ...... um-dependent insulin secretion
@en
Glutaredoxin-1 mediates NADPH- ...... um-dependent insulin secretion
@nl
prefLabel
Glutaredoxin-1 mediates NADPH- ...... um-dependent insulin secretion
@ast
Glutaredoxin-1 mediates NADPH- ...... um-dependent insulin secretion
@en
Glutaredoxin-1 mediates NADPH- ...... um-dependent insulin secretion
@nl
P2093
P2860
P356
P1476
Glutaredoxin-1 mediates NADPH- ...... um-dependent insulin secretion
@en
P2093
Dai-Qing Li
Erik Renström
Lena Stenson
Omid Niazi
Rosita Ivarsson
Ulrika Bryborn
Xingjun Jing
P2860
P304
P356
10.1210/ME.2008-0306
P577
2009-03-19T00:00:00Z